Contract facts
FederalSURV ETIOLOGY MALARIA IN MALAYSIA is a federal award for NAVSUP Flt Log Ctr Norfolk held by Vysnova Partners, Inc. Estimated value $779K ($643K obligated). Current period of performance ends Sep 28, 2025.
Recompete timing
PublicCurrent PoP ended Sep 28, 2025 (327 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordVysnova Partners, Inc — $50.5M obligated across 65 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract N0018924FZ381?
N0018924FZ381 (SURV etiology malaria in malaysia) is a NAVSUP Flt Log Ctr Norfolk award with a potential value of $779K, currently held by Vysnova Partners, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded N0018924FZ381?
NAVSUP Flt Log Ctr Norfolk awarded N0018924FZ381 to Vysnova Partners, Inc (potential $779K).
Who is the incumbent on N0018924FZ381?
Vysnova Partners, Inc is the incumbent with $50.5M across 65 related awards in SCOUT’s public footprint. The current period of performance ends Sep 28, 2025.
When does Vysnova Partners, Inc’s N0018924FZ381 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 28, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.